Synthetic drugs: What you need to know
Our webinar will provide an overview of synthetic drugs, review trends in usage and patterns and discuss the challenges for a workplace program.
New to drug testing: Synthetic marijuana
In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
Quest Diagnostics now tests for synthetic stimulants (bath salts)
Quest Diagnostics offers a comprehensive suite of drug testing products and services which now includes testing for synthetic stimulants (bath salts).
Synthetic cannabinoid user profile
The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of the CESAR report.
Synthetic cannabinoids linked to acute kidney injury
Acute kidney injury following exposure to synthetic cannabinoids, in sixteen cases, has been identified in six states.
DEA operation log jam
The DEA's Operation Log Jam was the first-ever nationwide law enforcement action against synthetic drugs.
Bloomberg Businessweek – Synthetic highs
Synthetic drugs using legal compounds but mimic the highs from marijuana to cocaine are proliferating among do-it-yourself pharma labs across the US.
Synthetic cannabinoid webinar recording
A recording of the seminar and presentation are now available online.
Webinar: K2, spice, bath salts, etc.
What Employers need to know about "Synthetic Cannabinoids", "Bath Salts" and other "Legal Highs".